市場調查報告書

全球醫療圖像分析軟體市場考察,機會分析,市場佔有率,預測

Global Medical Image Analysis Software Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 502717
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
全球醫療圖像分析軟體市場考察,機會分析,市場佔有率,預測 Global Medical Image Analysis Software Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023
出版日期: 2017年05月11日內容資訊: 英文 140 Pages
簡介

本報告提供全球醫療圖像分析軟體市場相關調查分析,市場概要,市場決策要素,市場區隔,競爭情形,各地區的分析,企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場:演進與轉移
  • 市場定義、範圍
  • 產業結構
  • 法律規範
  • 綜合市場分析
  • 評估分析
  • 策略分析
  • 競爭分析
  • 策略性建議主要的結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第4章 市場區隔

  • 市場:各類軟體
  • 市場:影像的各類型
  • 市場:各種模式
  • 市場:各用途
  • 市場:各終端用戶

第5章 競爭情形

  • 主要策略

第6章 各地區分析

  • 決策依據的資料庫、估計手法
  • 各市場區隔的比較分析
  • 機會矩陣
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第7章 企業簡介

  • AGFA-GEVAERT GROUP
  • AQUILAB
  • BARCO
  • BRUKER
  • CARESTREAM HEALTH, INC.
  • ELEKTA
  • ESAOTE
  • GENERAL ELECTRIC COMPANY (GE)
  • INFIMED
  • MERGE HEALTHCARE INC.
  • MIM SOFTWARE, INC.
  • PHILIPS HEALTHCARE
  • SIEMENS HEALTHCARE
  • 東芝 Medical Systems
  • XINAPSE SYSTEMS LTD.
目錄
Product Code: HHE-5340517

Global medical imaging analysis software market is anticipated to reach $3,335.3 million with a significant CAGR of 8.2% during 2016-2023. The medical imaging analysis software market growth is primarily attributed by the increasing investment in medical imaging technologies and increasing chronic disorders across the globe. Furthermore, the rapid increase in demand for technically progression market for imaging devices and increasing number of enduring research activities which results in the development of innovative and advanced products in the market is also adding meaningful growth in the global medical imaging analysis software market. However, high cost of software and rising hacking concerns is the primary factor that is restricting the growth in the global medical imaging analysis market.

The medical imaging analysis software market is segmented on the basis of software, image, modality, application and end-user. According to software segment, the market is further segmented such as integrated software and standalone software. On the basis of image segment, the market is further subdivided into 2D imaging, 3D imaging, and 4D imaging. On the basis of modality segment, the market is further divided into tomography (Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) and Single-Photon Emission Tomography (SPECT)), ultrasound imaging, radiographic imaging, and combined modalities. On the basis of application segment, the market is further subdivided into orthopedic application, dental applications, neurology, cardiology application, oncology applications, mammography applications and urology and nephrology applications. On the basis of end-user segment, the market is further subdivided into hospitals, diagnostic centers, and research centers.

On the basis of geography, the global medical imaging analysis software market is segmented into four major regions such as North America, APAC, Europe and RoW. In 2016 North America is accounted to be the largest market share for medical image analysis software due to increasing cloud based image analysis solutions and increasing incidences of chronic disease.. Asia Pacific is projected to be growing upward at the rapid CAGR during the prediction period due to rise in per capita income, technological advancements in diagnostic technology, and the increasing saturation of the medical imaging systems in fast developing economies of the Asia Pacific, such as India and China and increasing medical investment. Along with this, there are many other driving factors that are contributing to overall growth of the market such as high R&D investment in product launching, product innovation etc. by the major market player such as GE Healthcare, Philips Healthcare etc. , and investments in the healthcare industry.

Key manufacturing vendors actively engaged in the global image analysis market are Esaote S.p.A (Italy), Agfa HealthCare (Belgium), Carestream Health, Inc. (U.S.), Aquilab (France), GE Healthcare (U.K.), MIM Software Inc. (U.S.), Philips Healthcare (Netherlands), Merge Healthcare, Inc. (U.S.), Siemens Healthcare (Germany), and Toshiba Medical Systems Corporation (Japan).

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION AND SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. PRICING ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES AND ANALYSIS
    • 2.8.2. MARKET SHARE
    • 2.8.3. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING APPLICATIONS OF COMPUTER-AIDED DIAGNOSIS (CAD)
    • 3.1.2. GROWING USAGE OF IMAGING EQUIPMENT
    • 3.1.3. GROWING INCIDENCES OF CHRONIC DISEASES
    • 3.1.4. TECHNOLOGICAL DEVELOPMENTS IN MEDICAL IMAGING SYSTEMS AND ANALYSIS SOFTWARE
    • 3.1.5. INCREASING PUBLIC- AND PRIVATE-SECTOR INVESTMENTS IN THE MEDICAL IMAGING MARKET
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. HIGH COST OF SOFTWARE
    • 3.2.2. INCREASING SOFTWARE HACKING CONCERNS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. CLOUD-BASED IMAGE ANALYSIS SOLUTIONS
    • 3.3.2. EXPANSION IN DEVELOPING MARKETS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. MARKET PENETRATION OF STANDALONE SOFTWARE VENDORS
    • 3.4.2. ABSENCE OF SKILLED PROFESSIONALS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY SOFTWARE
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL INTEGRATED SOFTWARE MARKET
        • 4.1.5.1.1. APPLICATIONS
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL STANDALONE SOFTWARE MARKET
        • 4.1.5.2.1. APPLICATIONS
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
  • 4.2. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY IMAGE TYPE
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL 2D IMAGING MARKET
        • 4.2.5.1.1. APPLICATIONS
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL 3D IMAGING MARKET
        • 4.2.5.2.1. APPLICATIONS
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL 4D IMAGING MARKET
        • 4.2.5.3.1. APPLICATIONS
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
  • 4.3. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY MODALITY
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL TOMOGRAPHY MARKET
        • 4.3.5.1.1. APPLICATIONS
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL ULTRASOUND IMAGING MARKET
        • 4.3.5.2.1. APPLICATIONS
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL RADIOGRAPHIC IMAGING MARKET
        • 4.3.5.3.1. APPLICATIONS
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.3.5. KEY CONCLUSIONS
      • 4.3.5.4. GLOBAL COMBINED MODALITIES MARKET
        • 4.3.5.4.1. APPLICATIONS
        • 4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 4.3.5.4.5. KEY CONCLUSIONS
  • 4.4. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY APPLICATION
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBAL ORTHOPEDIC APPLICATIONS MARKET
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.1.4. KEY CONCLUSIONS
      • 4.4.5.2. GLOBAL DENTAL APPLICATIONS MARKET
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.2.4. KEY CONCLUSIONS
      • 4.4.5.3. GLOBAL NEUROLOGY MARKET
        • 4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.3.4. KEY CONCLUSIONS
      • 4.4.5.4. GLOBAL CARDIOLOGY APPLICATIONS MARKET
        • 4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.4.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.4.4. KEY CONCLUSIONS
      • 4.4.5.5. GLOBAL ONCOLOGY APPLICATIONS MARKET
        • 4.4.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.5.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.5.4. KEY CONCLUSIONS
      • 4.4.5.6. GLOBAL OBSTETRICS AND GYNECOLOGY APPLICATIONS MARKET
        • 4.4.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.6.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.6.4. KEY CONCLUSIONS
      • 4.4.5.7. GLOBAL MAMMOGRAPHY APPLICATIONS MARKET
        • 4.4.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.7.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.7.4. KEY CONCLUSIONS
      • 4.4.5.8. GLOBAL UROLOGY AND NEPHROLOGY APPLICATIONS MARKET
        • 4.4.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.8.3. TOP PLAYERS & KEY PRODUCTS
        • 4.4.5.8.4. KEY CONCLUSIONS
  • 4.5. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY END USER
    • 4.5.1. MARKET DEFINITION AND SCOPE
    • 4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.5.4. OPPORTUNITY MATRIX
    • 4.5.5. MARKET SEGMENTATION
      • 4.5.5.1. GLOBAL HOSPITALS MARKET
        • 4.5.5.1.1. APPLICATIONS
        • 4.5.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.1.5. KEY CONCLUSIONS
      • 4.5.5.2. GLOBAL DIAGNOSTIC CENTERS MARKET
        • 4.5.5.2.1. APPLICATIONS
        • 4.5.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.2.5. KEY CONCLUSIONS
      • 4.5.5.3. GLOBAL RESEARCH CENTERS MARKET
        • 4.5.5.3.1. APPLICATIONS
        • 4.5.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.5.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.5.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.5.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY REGION

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GEOGRAPHIC SEGMENTATION
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. ITALY
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
        • 6.4.2.2.6. REST OF EUROPE
          • 6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.6.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. SOUTH KOREA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. AUSTRALIA
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
        • 6.4.3.2.6. REST OF ASIA PACIFIC
          • 6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.6.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. AGFA-GEVAERT GROUP
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION/FOCUS SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. AQUILAB
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION/FOCUS SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. BARCO
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION/FOCUS SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. BRUKER
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION/FOCUS SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. CARESTREAM HEALTH, INC.
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION/FOCUS SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
    • 7.5.6. STRATEGIC ANALYSIS
  • 7.6. ELEKTA
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION/FOCUS SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. ESAOTE S.P.A
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION/FOCUS SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. GENERAL ELECTRIC COMPANY (GE)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION/FOCUS SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. INFIMED
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION/FOCUS SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. MERGE HEALTHCARE INC.
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION/FOCUS SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. MIM SOFTWARE, INC.
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION/FOCUS SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. PHILIPS HEALTHCARE
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION/FOCUS SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. SIEMENS HEALTHCARE
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION/FOCUS SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. TOSHIBA MEDICAL SYSTEMS CORPORATION
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION/FOCUS SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. XINAPSE SYSTEMS LTD.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION/FOCUS SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE 2014-2023 ($ MILLION)
  • TABLE 2. GLOBAL INTEGRATED SOFTWARE BY GEOGRAPHY 2014-2023 ($MILLION)
  • TABLE 3. GLOBAL STANDALONE SOFTWARE BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGE 2014-2023 ($ MILLION)
  • TABLE 5. GLOBAL 2D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 6. GLOBAL 3D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 7. GLOBAL 4D IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY 2014-2023 ($ MILLION)
  • TABLE 9. GLOBAL TOMOGRAPHY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 10. GLOBAL ULTRASOUND IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 11. GLOBAL RADIOGRAPHIC IMAGING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 12. GLOBAL COMBINED MODALITIES BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END-USER 2014-2023 ($ MILLION)
  • TABLE 14. GLOBAL HOSPITALS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 15. GLOBAL DIAGONAL CENTERS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 16. GLOBAL RESEARCH CENTERS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • TABLE 18. GLOBAL ORTHOPEDIC APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 19. GLOBAL DENTAL APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 20. GLOBAL NEUROLOGY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 21. GLOBAL CARDIOLOGY APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 22. GLOBAL ONCOLOGY APPLICATION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 23. GLOBAL OBSTETRICS AND GYNECOLOGY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 24. GLOBAL MAMMOGRAPHY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 25. GLOBAL UROLOGY AND NEPHROLOGY APPLICATIONS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 26. NORTH AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • TABLE 27. EUROPE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • TABLE 28. ASIA PACIFIC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • TABLE 29. REST OF THE WORLD MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY UROLOGY AND NEPHROLOGY APPLICATIONS 2014-2023($ MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAMMOGRAPHY APPLICATIONS 2014-2023 ($ MILLION)
  • FIGURE 3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OBSTETRICS AND GYNECOLOGY APPLICATIONS 2014-2023 ($ MILLION)
  • FIGURE 4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ONCOLOGY APPLICATION 2014-2023 ($ MILLION)
  • FIGURE 5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CARDIOLOGY APPLICATION 2014-2023 ($ MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY NEUROLOGY 2014-2023 ($ MILLION)
  • FIGURE 7. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DENTAL APPLICATIONS 2014-2023 ($ MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ORTHOPEDIC APPLICATION 2014-2023 ($ MILLION)
  • FIGURE 9. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HOSPITALS 2014-2023 ($ MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DIAGONALS CENTERS 2014-2023 ($ MILLION)
  • FIGURE 11. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RESEARCH CENTERS 2014-2023 ($ MILLION)
  • FIGURE 12. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY TOMOGRAPHY 2014-2023 ($ MILLION)
  • FIGURE 13. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ULTRASOUND IMAGING 2014-2023 ($ MILLION)
  • FIGURE 14. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RADIOGRAPHIC IMAGING 2014-2023 ($ MILLION)
  • FIGURE 15. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMBINED MODALITIES 2014-2023 ($ MILLION)
  • FIGURE 16. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D 2014-2023 ($ MILLION)
  • FIGURE 17. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D 2014-2023 ($ MILLION)
  • FIGURE 18. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 4D 2014-2023 ($ MILLION)
  • FIGURE 19. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY INTEGRATED SOFTWARE 2014-2023 ($ MILLION)
  • FIGURE 20. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY STANDALONE SOFTWARE 2014-2023 ($ MILLION)
  • FIGURE 21. UNITED STATES (U.S.) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 22. CANADA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 23. UNITED KINGDOM (UK) MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 24. FRANCE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 25. GERMANY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 26. SPAIN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 27. ITALY MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 28. ROE MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 29. INDIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 30. CHINA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 31. JAPAN MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 32. KOREA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 33. AUSTRALIA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 34. ROAPAC MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 35. LATIN AMERICA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)
  • FIGURE 36. MENA MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 2014-2023 ($ MILLION)